What are the essential components of HIV treatment and care services in low and middle-income countries: An overview by settings and levels of the health system?

AIDS

Volumn 26, Issue SUPPL.2, 2012, Pages

  Munderi, Paula ^a   Grosskurth, Heiner ^a,b   Droti, Benson ^a   Ross, David A ^b  

^a UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; COTRIMOXAZOLE; FLUCONAZOLE; ISONIAZID;

ARTICLE; BACTERIAL INFECTION; CARDIOVASCULAR RISK; CD4 LYMPHOCYTE COUNT; CRYPTOCOCCAL MENINGITIS; DECENTRALIZATION; DRUG EFFICACY; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE SYSTEM; HEALTH SERVICE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LABORATORY DIAGNOSIS; LOWEST INCOME GROUP; MALARIA; MENTAL HEALTH CARE; NUTRITIONAL SUPPORT; OPPORTUNISTIC INFECTION; PATIENT COUNSELING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; REPRODUCTIVE HEALTH; SEXUAL HEALTH; TUBERCULOSIS; VERTICAL TRANSMISSION; VIRUS LOAD;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DELIVERY OF HEALTH CARE, INTEGRATED; DEVELOPING COUNTRIES; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; PATIENT ACCEPTANCE OF HEALTH CARE; REPRODUCTIVE HEALTH SERVICES;

EID: 84872857207     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32835bdde6     Document Type: Article

References (39)

1. WHO. Global Burden of Disease report. June 2011; http://www.who.int/ mediacentre/factsheets/fs310/en/index.html [Accessed on 1 November 2012].
2. WHO, UNAIDS, UNICEF. Global HIV/AIDS response, Epidemic update and Health sector progress towards Universal Access, Progress Report 2011.
3. Jaffar S, Govender T, Garrib A, Welz T, Grosskurth H, Smith P. Antiretroviral treatment in resource-poor settings: public health research priorities. Trop Med Int Health 2005; 10:295-299. (Pubitemid 40569246)
4. Weigel R, Kamthunzi P, Mwansambo C, Phiri S, Kazembe PN. Effect of provider-initiated testing and counselling and integration of ART services on access to HIV diagnosis and treatment for children in Lilongwe, Malawi: a pre post comparison. BMC Pediatr 2009; 9:80.
5. Thompson MA, Aberg JA, Cahn P, Montaner JS, Rizzardini G, Telenti A, et al. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA 2010; 304:321-333.
6. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. for the HPTN 052 study team. Prevention of HIV-1 Infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505.
7. Parkes-Ratanshi R, Bufumbo L, Nyanzi-Wakholi B, Levin J, Grosskurth H, Lalloo DG, Kamali A. Barriers to starting ART and how they can be overcome: individual and operational factors associated with early and late start of treatment. Trop Med Int Health 2010; 15:1347-1356.
8. Foster S, Nakamanya S, Amurwon J, Kyomuhangi R, Namara G, Amuron B, et al. The experience of 'medicine companions' to support adherence to antiretroviral therapy: quantitative and qualitative data from a trial population in Uganda. AIDS Care 2010; 22 (Suppl 1):35-43.
9. Chintu C, Bhat GJ, Walker AS, Mulenga V, Sinyinza S, Lishimpi K, et al. Cotrimoxazole as prophylaxis against opportunistic infections as HIV infected Zambian children (CHAP): a doubleblind randomised placebo-controlled trial. Lancet 2004; 364:1865-1871. (Pubitemid 39536090)
10. Mwangulu F, Floyd S, Crampin A, Kasimba S, Malema S, Kanyongoloka H, et al. Cotrimoxazole prophylaxis reduces mortality in human immunodeficiency virus-positive tuberculosis patients in Karonga District, Malawi. Bull World Health Org 2004; 82:354-363. (Pubitemid 38715072)
11. WHO. Guidelines on co-trimoxazole prophylaxis for HIV-related infections among children, adolescents and adults: recommendations for a public health approach, World Health Organisation 2006. http://www.who.int/hiv/pub/guidelines/ ctxguidelines.pdf [Accessed on 1 November 2012].
12. Golub JE, Pronyk P, Mohapi L, Thsabangu N, Moshabela M, Struthers H, et al. Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort. AIDS 2009; 23:631-636.
13. Granich R, Akolo C, Gunneberg C, Getahun H, Williams P, Williams B. Prevention of tuberculosis in people living with HIV. Clin Infect Dis 2010; 50 (Suppl 3):S215-S222.
14. Parkes-Ratanshi, Wakeham K, Levin J, Namusoke D, Whitworth J, Coutinho A, et al. On behalf of the Cryptococcal Trial Team. Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial. Lancet Infect Dis 2011; 11:933-941.
15. Walensky RP, Paltiel AD, Losina E, Mercincavage LM, Schackman BR, Sax PE, et al. The survival benefits of AIDS treatment in the United States. JID 2006; 194:11-19.
16. WHO. Safe and effective use of antiretroviral treatments with particular reference to resource limited settings. WHO/ HSI/2000.04. 2000. http://data.unaids.org/publications/external-documents-restored/ who-hsi-2000-04-en.pdf [Accessed on 13 November 2012].
17. Wamoyi J, Mbonye M, Seeley J, Birungi J, Jaffar S. Changes in sexual desires and behaviours of people living with HIV after initiation of ART: Implications for HIV prevention and health promotion. BMC Public Health 2011; 11:633.
18. Homsy J, Bunnell R, Moore D, King R, Malamba S, Nakityo R, et al. Reproductive intentions and outcomes among women on antiretroviral therapy in rural uganda: a prospective cohort study. PLoS ONE 2009; 4:e4149. doi:10.1371/journal.- pone.0004149.
19. Deeks SG, Phillips AN. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ 2009; 338:a3172 doi:10.1136/bmj.a3172.
20. Wester WC, Koethe JR, Sheperd BE, Stinette SE, Rebeiro PF, Kipp AM, et al. Non-AIDS-defining events among HIV-1-infected adults receiving combination antiretroviral therapy in resource-replete versus resource-limited urban setting. AIDS 2011; 25:1471-1479.
21. Adewaya AO, Afolabi MO, Ola BA, Oquendele OA, Ajibare AO, Oladipo BF. Psychiatric disorders among the HIV- positive population in Nigeria: a control study. J Psychosomatic Res 2007; 63:203-206. (Pubitemid 47088555)
22. Petrushkin A, Boardman J, Ovuga E. Psychiatric disorders in HIV-positive individuals in urban Uganda. Psychiatr Bull 2005; 29:455-458. (Pubitemid 41819271)
23. Chishinga N, Kinyanda E, Weiss HA, Patel V, Ayles H, Seedat S. Validation of brief screening tools for depressive and alcohol use disorders among TB and HIV patients in primary care in Zambia. BMC Psychiatry 2011; 11:75.
24. Wanke C. Pathogenesis and consequences of HIV-associated wasting. JAIDS 2004; 37:S277-S279. (Pubitemid 39602329)
25. Tang AM, Lanzillotti J, Hendricks K, Gerrior J, Ghosh M, Woods M, Wanke C. Micronutrients: current issues for HIV care providers. AIDS 2005; 19:847-861; http://www.who.int/nutrition/topics/consultation-nutrition-and-hivaids/en/ index.html. (Pubitemid 40834927)
26. WHO. Consultation on Nutrition and HIV/AIDS in Africa: Evidence, lessons and recommendations for action. WHO, Geneva, 2005. http://www.who.int/nutrition/ topics/consultation-nutrition-and-hivaids/en/index.html.
27. Nerad J, Romeyn M, Silverman E, Allen-Reid J, Dieterich D, Merchant J, et al. General nutrition management in patients infected with human immunodeficiency virus. Clin Infect Dis 2003; 36 (Suppl 2):S52-S62. (Pubitemid 36408112)
28. DART Trial Team: routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised noninferiority trial. Lancet 2010; 375: 123-131.
29. Calmy A, Ford N, Hirschel B, Reynolds SJ, Lynen L, Goemaere E, Rodriguez W. HIV viral load monitoring in resource-limited regions: optional or necessary? Clin Infect Dis 2007; 44: 128-134. (Pubitemid 44968997)
30. Kantor R, Diero L, Delong A, Kamle L, Muyonga S, Mambo F, et al. Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings. Clin Infect Dis 2009; 49:454-462.
31. UNAIDS Report. Chronic care of HIV and noncommunicable diseases. How to leverage the HIV experience 2011. http://www.unaids.org/en/media/unaids/ contentassets/documents/unaidspublication/2011/20110526-JC2145-Chronic-care-of- HIV.pdf [Accessed on 13 November 2012].
32. Sanne I, Orrell C, Fox MP, Conradie F, Ive P, Zeinecker J, et al. Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised noninferiority trial. Lancet 2010; 376:33-40.
33. Miles K, Clutterbuck DJ, Seitio O, Sebego M, Riley A. Antiretroviral treatment roll-out in a resource-constrained setting: capitalizing on nursing resources in Botswana. doi: 10.2471/ BLT.06.033076. Bull World Health Organ 2007; 85:555-560. (Pubitemid 47041635)
34. Bemelmans M, Van Den Akker T, Ford N, Philips M, Zachariah R, Harries A, et al. Providing universal access to antiretroviral therapy in Thyolo, Malawi through task shifting and decentralization of HIV/AIDS care. Trop Med Int Health 2010; 15:1413-1420.
35. Jaffar S, Amuron B, Foster S, Birungi J, Levin J, Namara G, et al. on behalf of the Jinja trial team: Rates of virological failure in patients treated in a home-based versus a facility-based HIVcare model in Jinja, SE Uganda - a cluster-randomised equivalence trial. The Lancet 2009; 374:2080-2089.
36. Schneider H, Hlophe H, van Rensburg D. Community health workers and the response to HIV/AIDS in South Africa: tensions and prospects. Health Pol Plann 2008; 23:179-187.
37. Gilks C, Crowley S, Ekpini R, Gove S, Perriens J, Souteyrand Y, et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet 2006; 368:505-510. (Pubitemid 44142772)
38. WHO Guidelines: http://www.who.int/hiv/pub/guidelines/en [Accessed on 1 November 2012].
39. Lifshay J, Nakayiwa S, King R, Reznick OG, Katuntu D, Batamwita R, et al. Partners at risk: motivations, strategies, and challenges to HIV transmission risk reduction among HIVinfected men and women in Uganda. AIDS Care 2009; 21:715-724.